Benzinga | Aug 11, 2020 11:25AM EDT

HC Wainwright & Co. Maintains Buy on Homology Medicines, Lowers Price Target to $30

HC Wainwright & Co. maintains Homology Medicines (NASDAQ:FIXX) with a Buy and lowers the price target from $37 to $30.